Introduction• Development of atherosclerotic plaques• Dyslipidaemia is a major risk factor for
atherosclerosis• Myeloid cells in atherosclerosis and effects of hyperlipidaemia–Monocytes …

Myeloid cells in atherosclerosis: a delicate balance of anti... : Current Opinion in Lipidology
Myeloid cells in atherosclerosis: a delicate balance of anti-inflammatory and proinflammatory …

Atherosclerosis, the major risk factor for cardiovascular disease (CVD) and the leading
cause of death worldwide, is a multifactorial chronic inflammatory disease, which, clinically …

Chronic inflammation is the underlying pathophysiological mechanism of atherosclerosis.
Prominent suspects being involved in atherosclerosis are lymphocytes, platelets, and …

Atherosclerosis is one of the leading causes of death and disability worldwide. It is a
complex disease characterized by lipid accumulation within the arterial wall, inflammation …

Inflammation furnishes a series of pathogenic pathways that couple the risk factors for
atherosclerosis with altered behavior of the intrinsic cells of the arterial wall, endothelium …

Monocytosis and neutrophilia are frequent events in atherosclerosis. These phenomena
arise from the increased proliferation of hematopoietic stem and multipotential progenitor …

Endothelial dysfunction and inflammation of the arterial wall continuously drive the
development of atherosclerosis. Details regarding the sequential involvement of different …

New vessel formation inside the arterial wall and atherosclerotic plaques plays a critical role
in pathogenesis of heart attacks and strokes. The 2 known mechanisms resulting in the …

Atherosclerosis, the major pathological process through which arterial plaques are formed,
is a dynamic chronic inflammatory disease of large‐and medium‐sized arteries in which the …